American Journal of Kidney Diseases

Slides:

Advertisements

Similar presentations

Volume 61, Issue 2, Pages (August 2014)

Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Assessment and Diagnosis of Renal Dysfunction in the ICU

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,

Chronic Kidney Disease in Diabetes

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,

Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate Szu-Yuan Li, MD, Chiao-Lin Chuang, MD,

Diagnosis and Management of Chronic Kidney Disease

Uric Acid as a Target of Therapy in CKD

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Development of Reduced Kidney Function in Rheumatoid Arthritis

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

A Decade After the KDOQI CKD Guidelines

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Kaiser Permanente Creatinine Safety Program: A Mechanism to Ensure Widespread Detection and Care for Chronic Kidney Disease John J. Sim, MD, Mark P.

Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study Simon Sawhney, MBChB, Angharad.

Cardiovascular Disease and CKD: Core Curriculum 2010

Matei Neagu, PhD, Daniel Coca, PhD, Albert C.M. Ong, DM

Chronic Kidney Disease in Diabetes

Prehypertension and chronic kidney disease: the ox or the plow?

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

Recognition for Conservative Care in Kidney Failure

John P. Middleton, Patrick H. Pun Kidney International

Improving Carboplatin Dosing Based on Estimated GFR

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.

Your Kidneys May Outlive You

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care Douglas S.

Erratum American Journal of Kidney Diseases

Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis Xiaole Su, MD, Lu Zhang, MD, Jicheng Lv, MD, PhD, Jinwei Wang, PhD,

Podocyte Lesions in Patients With Obesity-Related Glomerulopathy

Ioannis Koulouridis, MD, MS, Lori Lyn Price, MAS, Nicolaos E

Hypomagnesemia in a Patient With an Eating Disorder

Volume 84, Issue 1, Pages (July 2013)

Management of Heart Failure in Advancing CKD: Core Curriculum 2018

Kathleen D. Liu, Jingrong Yang, Thida C. Tan, David V

Quiz Page July 2012 American Journal of Kidney Diseases

Volume 75, Issue 1, Pages (January 2009)

Polyunsaturated Fatty Acids and Kidney Disease

Michael F. Flessner, MD, PhD, Sharon B. Wyatt, PhD, Ermeg L

Kidney Disease Among African Americans: A Population Perspective

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Salicylate Intoxication as a Cause of Pseudohyperchloremia

Distribution of Measured GFR in Apparently Healthy Chinese Adults

American Journal of Kidney Diseases

Quiz Page April 2008 American Journal of Kidney Diseases

Evidence and Outcomes in CKD

Drug Dose Adjustments in Patients With Renal Impairment

Methods for guideline development

Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD

Quiz Page August 2007 American Journal of Kidney Diseases

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Improving Carboplatin Dosing Based on Estimated GFR

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Volume 80, Issue 10, Pages (November 2011)

Was It the Nephrologists or the Fluid?

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Patient Safety Issues in CKD: Core Curriculum 2015

This Month in AJKD American Journal of Kidney Diseases

American Journal of Kidney Diseases

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

American Journal of Kidney Diseases Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study Kim N. Danforth, Erin E. Hahn, Jeffrey M. Slezak, Lie Hong Chen, Bonnie H. Li, Corrine E. Munoz-Plaza, Tiffany Q. Luong, Teresa N. Harrison, Brian S. Mittman, John J. Sim, Hardeep Singh, Michael H. Kanter American Journal of Kidney Diseases DOI: 10.1053/j.ajkd.2019.05.003 Copyright © 2019 The Authors Terms and Conditions

Figure 1 Follow-up of incident abnormal estimated glomerular filtration rate (eGFR) results: distribution of care-gap frequency by physician (among physicians with at least 10 eligible patients). Patients were considered to have a care gap in the follow-up of an incident abnormal eGFR result if they did not experience one of the following: a repeat creatinine laboratory test 60 to 150 days after the incident abnormal laboratory result, an earlier repeat creatinine test indicating normal kidney function, or a diagnosis of chronic kidney disease or kidney cancer before 60 days. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.05.003) Copyright © 2019 The Authors Terms and Conditions